Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 14:15:1358578.
doi: 10.3389/fpsyt.2024.1358578. eCollection 2024.

Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia

Affiliations
Review

Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia

Jinyoung Choi et al. Front Psychiatry. .

Abstract

Bipolar disorder and schizophrenia are serious psychiatric conditions that cause a significant reduction in quality of life and shortened life expectancy. Treatments including medications and psychosocial support exist, but many people with these disorders still struggle to participate in society and some are resistant to current therapies. Although the exact pathophysiology of bipolar disorder and schizophrenia remains unclear, increasing evidence supports the role of oxidative stress and redox dysregulation as underlying mechanisms. Oxidative stress is an imbalance between the production of reactive oxygen species generated by metabolic processes and antioxidant systems that can cause damage to lipids, proteins, and DNA. Sleep is a critical regulator of metabolic homeostasis and oxidative stress. Disruption of sleep and circadian rhythms contribute to the onset and progression of bipolar disorder and schizophrenia and these disorders often coexist with sleep disorders. Furthermore, sleep deprivation has been associated with increased oxidative stress and worsening mood symptoms. Dysfunctional brain metabolism can be improved by fatty acid derived ketones as the brain readily uses both ketones and glucose as fuel. Ketones have been helpful in many neurological disorders including epilepsy and Alzheimer's disease. Recent clinical trials using the ketogenic diet suggest positive improvement in symptoms for bipolar disorder and schizophrenia as well. The improvement in psychiatric symptoms from the ketogenic diet is thought to be linked, in part, to restoration of mitochondrial function. These findings encourage further randomized controlled clinical trials, as well as biochemical and mechanistic investigation into the role of metabolism and sleep in psychiatric disorders. This narrative review seeks to clarify the intricate relationship between brain metabolism, sleep, and psychiatric disorders. The review will delve into the initial promising effects of the ketogenic diet on mood stability, examining evidence from both human and animal models of bipolar disorder and schizophrenia. The article concludes with a summary of the current state of affairs and encouragement for future research focused on the role of metabolism and sleep in mood disorders.

Keywords: bipolar disorder; ketogenic diet; metabolism; schizophrenia; sleep.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Similar articles

Cited by

References

    1. Levenberg K, Cordner ZA. Bipolar depression: a review of treatment options. Gen Psychiatry (2022) 35(4):e100760. doi: 10.1136/gpsych-2022-100760 - DOI - PMC - PubMed
    1. Stępnicki P, Kondej M, Kaczor AA. Current concepts and treatments of schizophrenia. Molecules (2018) 23(8):2087. doi: 10.3390/molecules23082087 - DOI - PMC - PubMed
    1. Dean OM, Gliddon E, Van Rheenen TE, Giorlando F, Davidson SK, Kaur M, et al. . An update on adjunctive treatment options for bipolar disorder. Bipolar Disord (2018) 20(2):87–96. doi: 10.1111/bdi.12601 - DOI - PubMed
    1. Jimenez-Fernandez S, Gurpegui M, Garrote-Rojas D, Gutierrez-Rojas L, Carretero MD, Correll CU. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disord (2021) 23(2):117–29. doi: 10.1111/bdi.12980 - DOI - PubMed
    1. Kim Y, Santos R, Gage FH, Marchetto MC. Molecular mechanisms of bipolar disorder: Progress made and future challenges. Front Cell Neurosci (2017) 11:30. doi: 10.3389/fncel.2017.00030 - DOI - PMC - PubMed

LinkOut - more resources